Dr. Sides is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1430 Tulane Ave #8078
New Orleans, LA 70112Phone+1 504-503-6708Fax+1 504-988-5483
Summary
- Dr. Mark Sides is Director of Thoracic Medical Oncology at Tulane University School of Medicine in New Orleans, LA and is affiliated with Tulane Health System, East Jefferson Hospital System, University Hospital System and LCMC Hospital System. He received his PhD in Virology, post-doctoral fellowship studying virus-driven cancers and was a cancer researcher at Tulane University School of Medicine. He then received his MD from Tulane University School of Medicine and Internal Medicine and Medical Oncology Fellowship at University of Texas Medical Branch. He specializes in thoracic cancer, cancer research and clinical trials.
Education & Training
- University of Texas Medical Branch HospitalsFellowship, Medical Oncology, 2018 - 2020
- University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2015 - 2018
- Tulane University School of MedicineClass of 2015
- Tulane University School of MedicinePost-Doctoral Fellowship, 2010 - 2011
- Tulane University School of MedicinePhD, Virology, 2006 - 2010
- Coastal Carolina UniversityB.S., Chemistry, Biochemistry, 2003 - 2006
- Lander UniversityNo degree, Economic History, 1987 - 1988
- University of South CarolinaNo degree, Finance/Economics, 1985 - 1987
- University of South CarolinaNo degree, Honors Program, 1983 - 1985
Certifications & Licensure
- LA State Medical License 2020 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Board of Regents Graduate Fellowship, Tulane University School of Medicine Louisiana Board of Reagents
- Dame Cicely Saunders Award for Compassionate Care of Patients UTMB Internal Medicine Residency Program
- Dean's Board of Advisors Coastal Carolina University
- Join now to see all
Publications & Presentations
PubMed
- 43 citationsThe Epstein-Barr Virus Latent Membrane Protein 1 and Transforming Growth Factor–β1 Synergistically Induce Epithelial–Mesenchymal Transition in Lung Epithelial CellsMark D Sides, Ross C. Klingsberg, Bin Shan, Kristin A. Gordon, Hong T. Nguyen
American Journal of Respiratory Cell and Molecular Biology. 2011-06-01 - 48 citationsArsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivoFayong Luo, Yan Zhuang, Mark D Sides, Cecilia G. Sanchez, Bin Shan
Respiratory Research. 2014-04-24 - 9 citationsArsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cellsQinyan Yin, Mark D Sides, Chris Parsons, Erik K. Flemington, Joseph A. Lasky
Virology Journal. 2017-06-21
Journal Articles
- Neoadjuvant Radiation with Concurrent 5-FU Resulting in Complete Pathologic Response in Stage IIIB Squamous Cell Carcinoma of the UrethraKrishna H. Suthar, Meghana Kesireddy , Mark Sides, Amit Correa, Aijan Ukudeyva, and Rohit Venkatesan, Case Rep Oncol Med, 2/14/2020
Abstracts/Posters
- A Very Unusual Case of ST segment Elevation Myocardial Infarction due to Invasive LymphomaM. Waqas Choudhry, Hussain Ibrahim, Tareq A bu Sharifeh, Mark Sides, Luba Frank, Rafic Berbarie, American College of Cardiology/American Heart Association Joint Meeting, San Diego, CA, 1/1/2017
- Arsenic Trioxide Abrogates TFF-Beta1 Induced Fibroblast to Myofibroblast TransdifferentationLuo F, Sides MD, Shan B, Lasky JA, Journal of Investigative Medicine, 2/2011
- Arsenic Mediated Disruption of Promyelocytic Leukemia Protein Nuclear Bodies Reactivates Epstein-Barr Virus and Induces Ganciclovir SusceptibilitySides MD, Block GJ, Esteves KC, Lin Z , Flemington EK , Lasky JA, Journal of Investigative Medicine, 2/2011
- Join now to see all
Lectures
- Management of the Patient in Acute Sickle Cell Crisis1/9/2018
- Palliative Care for the Kenyan Population: A Temporal ApproachAIC Kijabe Hospital, Kijabe, Kenya - 1/3/2018
- Exercise as Medicine: Broadening the scope of Physical/Occupational Therapy, Cardiac/Pulmonary Rehabilitation and Clinical Medical Exercise programsTulane University School of Medicine, New Orleans - 11/1/2012
- Join now to see all
Press Mentions
- Lung Cancer Survival in Louisiana Among Worst in U.S., but New Treatments Can HelpNovember 20th, 2024
- Tulane Thoracic Oncology ProgramJune 25th, 2022
Research History
- Assistant Professor- Clinical trials in Thoracic Oncology - Tissue Bank and Therapeutics in Small Cell Lung Cancer - EBV in the Lung Cancer Microenvironment - HPV in Squamous Cell Carcinoma of the Lung - Improvement in Healthcare Delivery2020 - Present
- Research ScientistEpstein-Barr Virus Driven Cancers
- Research ScientistEpstein-Barr Virus association with Pulmonary fibrosis
Professional Memberships
- Member
- Member
- Member
- Member
External Links
- Tulane School of Medicinehttps://medicine.tulane.edu/departments/medicine-hematology-medical-oncology-tulane-cancer-center/faculty/mark-sides-md-phd
- Tulane Medical Centerhttps://tulanehealthcare.com/physicians/profile/Dr-Mark-Sides-MD-PhD
- TMC Lung Cancer Programhttps://tulanehealthcare.com/service/lung-cancer
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: